Some people may joke about living on caffeine, but scientists now have genetically engineered E. coli bacteria to do that — literally. Their report in the journal ACS Synthetic Biology describes ba...
Global Challenges/Chemistry Solutions
Followers
0
Taking inspiration from trees, scientists have developed a battery made from a sliver of wood coated with tin that shows promise for becoming a tiny, long-lasting, efficient and environmentally friendly energy source. Their report on the device — 1,000 times thinner than a sheet of paper — appears in the journal Nano Letters.
Listen to Episode
Combating Disease: Genetically-engineered spider silk for gene therapy
Genetically engineered spider silk could help overcome a major barrier to the use of gene therapy in everyday medicine, according to a new study that reported development and successful initial laboratory tests of such a material. It appears in ACS’ journal Bioconjugate Chemistry.
Know someone who would enjoy this episode? Share a link to this episode with a friend.
Embed this episode on your website
More Like This
-
-
Day 6 from CBC Radio
Episode 270: Uploading police violence, GM mosquitoes versus Zika, Woody Guthrie takes on Trump and more
2 weeks agoEpisode 270: Video uploads of police violence, combating Zika with genetically modified mosquitoes, Woody Guthrie takes on "Old Man Trump," the democratic value of newspapers, and more.
-
3 weeks ago
Seattle musician Camille Bloom has Celiac Disease. She and over 3 million other Americans can't eat anything that contains even a trace of gluten; (no donuts, no bread, no crackers, no pizza) witho...
-
PeerView Clinical Pharmacology CME/CNE/CPE Video
Aaron Boster, MD - Transitioning to Another Disease-Modifying Therapy in Patients With MS Experiencing Poor Treatment Tolerability and/or Adherence: How and When?
Transitioning to Another Disease-Modifying Therapy in Patients With MS Experiencing Poor Treatment Tolerability and/or Adherence: How and When?
-
PeerView Clinical Pharmacology CME/CNE/CPE Audio Podcast
Aaron Boster, MD - Transitioning to Another Disease-Modifying Therapy in Patients With MS Experiencing Poor Treatment Tolerability and/or Adherence: How and When?
Transitioning to Another Disease-Modifying Therapy in Patients With MS Experiencing Poor Treatment Tolerability and/or Adherence: How and When?
-
PeerView Neuroscience & Psychiatry CME/CNE/CPE Audio Podcast
Aaron Boster, MD - Transitioning to Another Disease-Modifying Therapy in Patients With MS Experiencing Poor Treatment Tolerability and/or Adherence: How and When?
Transitioning to Another Disease-Modifying Therapy in Patients With MS Experiencing Poor Treatment Tolerability and/or Adherence: How and When?
-
PeerView Family Medicine & General Practice CME/CNE/CPE Video Podcast
Aaron Boster, MD - Transitioning to Another Disease-Modifying Therapy in Patients With MS Experiencing Poor Treatment Tolerability and/or Adherence: How and When?
Transitioning to Another Disease-Modifying Therapy in Patients With MS Experiencing Poor Treatment Tolerability and/or Adherence: How and When?
-
PeerView Family Medicine & General Practice CME/CNE/CPE Audio Podcast
Aaron Boster, MD - Transitioning to Another Disease-Modifying Therapy in Patients With MS Experiencing Poor Treatment Tolerability and/or Adherence: How and When?
Transitioning to Another Disease-Modifying Therapy in Patients With MS Experiencing Poor Treatment Tolerability and/or Adherence: How and When?
-
PeerView Neuroscience & Psychiatry CME/CNE/CPE Video Podcast
Aaron Boster, MD - Transitioning to Another Disease-Modifying Therapy in Patients With MS Experiencing Poor Treatment Tolerability and/or Adherence: How and When?
Transitioning to Another Disease-Modifying Therapy in Patients With MS Experiencing Poor Treatment Tolerability and/or Adherence: How and When?
